Skip to main content
Thomas George Jr., MD, Oncology, Gainesville, FL

ThomasJGeorgeJr.MDFACP

Oncology Gainesville, FL

Gastrointestinal Cancer, Clinical Pharmacology, Clinical Informatics

Professor, Medicine, University of Florida College of Medicine

Dr. George is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. George's full profile

Already have an account?

  • Office

    1600 PO Box
    Gainesville, FL 32610
    Phone+1 352-265-0101

Education & Training

  • University of Florida
    University of FloridaFellowship, Hematology and Medical Oncology, 2002 - 2005
  • University of Florida
    University of FloridaResidency, Internal Medicine, 1998 - 2002
  • University of Florida College of Medicine
    University of Florida College of MedicineClass of 1998

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1999 - 2025
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Using Photography to Explore Psychological Distress in Patients with Pancreatic Cancer and Their Caregivers: A Qualitative Study  
    Thomas George Jr., MD, Supportive care in cancer

Lectures

  • NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC)—First experimental arm (EA) initial resu... 
    2019 ASCO Annual Meeting - 6/1/2019
  • Phase II study of durvalumab following neoadjuvant chemoRT in stage II-IV rectal cancer: NSABP FR-2. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Final results from a phase II study of 5-fluorouracil, oxaliplatin, and dasatinib (FOLFOX-D) in previously untreated metastatic pancreatic adenocarcinoma. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
  • Join now to see all

Press Mentions

  • NRG Trial Suggests Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer Is Safe
    NRG Trial Suggests Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer Is SafeJune 1st, 2019
  • How Social Media Can Advance Cancer Research
    How Social Media Can Advance Cancer ResearchFebruary 15th, 2019
  • UM, UF Research Team Gets $3.2M Grant To Study Cannabis in Breast Cancer Treatments
    UM, UF Research Team Gets $3.2M Grant To Study Cannabis in Breast Cancer TreatmentsNovember 15th, 2023
  • Join now to see all

Professional Memberships